NDAINJECTIONINJECTABLE
Approved
Aug 1999
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 24m ago · AI intelligence enriched 1w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Chirocaine is a local anesthetic containing levobupivacaine hydrochloride, the S-enantiomer of bupivacaine, administered by injection for regional anesthesia and pain management. It is used to provide localized numbing for surgical procedures and acute/chronic pain control. The drug works by blocking sodium channels in nerve fibers, preventing pain signal transmission.
LOE Approaching
Product approaching loss of exclusivity with moderate competitive pressure (30/100), indicating reduced investment in growth initiatives and potential team restructuring.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on Chirocaine offers limited career growth opportunities given the product's LOE-approaching lifecycle and zero linked job openings. Roles on this product are primarily defensive and maintenance-focused, with emphasis on market retention rather than innovation.
Brand ManagerField Sales Representative
Worked on CHIROCAINE at Purdue Pharma? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.